RNA-seq from the prosencephalon of 12-day-old embryo from control and diabetic rats

Insight on the understanding of the effect of maternal diabetes on embryonic nervous system development in embryos without neural tube defects. Control Group: Each sample (n) contained the RNA obtained by TRIZOL of a bulk of 30 prosencephalons (embryo day 12) of embryos from both sexes obtained from pregnant rats that were intraperitoneally injected with citrate buffer. n=3 Experimental group: Each sample (n) contained the RNA obtained by TRIZOL of A bulk of 30 prosencephalons (embryo day 12) of embryos from both sexes obtained from pregnant rats that were diabetic induced with an intraperitoneal administration of 50 mg/kg of streptozotocin. n=3 The sequence liberties were obtained through paired-end sequencing experiments. Codes for the files are as follows: Control E12: AM1_S1_R1_001.fastq.gz AM1_S1_R2_001.fastq.gz AM2_S2_R1_001.fastq.gz AM2_S2_R2_001.fastq.gz AM3_S3_R1_001.fastq.gz AM3_S3_R2_001.fastq.gz Diabetic E12: AM4_S4_R1_001.fastq.gz AM4_S4_R2_001.fastq.gz AM5_S5_R1_001.fastq.gz AM5_S5_R2_001.fastq.gz AM6_S6_R1_001.fastq.gz AM6_S6_R2_001.fastq.gz Were S = sample, R1 = sense sequencing, and R2 = antisense sequencing. Sequencing was performed on a NextSeq500 using the TruSeq HT kit from Illumina.